Sandu Pharmaceuticals Ltd — Important, 22-12-2025: Company Update

Sandu Pharmaceuticals received a notice from the Maharashtra Goods & Service Tax Department regarding discrepancies in its FY2023-24 GST return. This notice highlights a non-reversal of Input Tax Credit (ITC) amounting to Rs 0.13 Cr. The company is preparing a response to the authorities. Management, supported by legal advice, is confident of a favorable outcome. Therefore, Sandu Pharmaceuticals does not foresee any financial, operational, or business impact from this notice.